Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Am J Transplant. 2020 Jul 7;20(12):3620–3630. doi: 10.1111/ajt.16113

Figure 1.

Figure 1.

Approach to desensitization. a) All candidates (n=4) were treated with multiple cycles of PI therapy and belatacept. Plasmapheresis was added in cases 3 (cycle 2, 3) and 4. (b) Detailed protocol for a representative case (case 3). Bela, belatacept; Bort, bortezomib; Carfilz, carfilzomib; Dex, dexamethasone; IVIG, intravenous immunoglobulin; Pheresis, plasmapheresis; Txp, transplant.

*Case 4 not transplanted